Press Releases
Back to Previous Page
 


News Release
November 18, 2016
Your Contact:
Karen Tiano +1 978-495-0093

MilliporeSigma named ‘Top Place to Work’ by The Boston Globe
  • Company receive recognition based on positive employee survey responses
  • Employees cite strong company values & ethics
  • Second acknowledgement of a leading employer ranking by a top publication

Billerica, Massachusetts, November 18, 2016 MilliporeSigma today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list.

This award marks the second of its kind in as many months. Last month, Merck KGaA, Darmstadt, Germany, ranked number 11 among the top 20 employers in the global biopharmaceutical industry by Science magazine, a leading peer-reviewed international scientific publication.

“The recognition by The Boston Globe as a leading employer reflects our commitment to build a great science and technology company in the U.S., in one of the leading biotech and healthcare hubs in the world,” said Udit Batra, CEO of the global life science business of Merck KGaA, Darmstadt, Germany and Member of the Executive Board. “We place great importance on fostering an environment that engenders both creative collaboration and problem solving. It’s a win-win for both our employees and customers as we work together to advance science and medicine.”

The Boston Globe’s research partner, Workplace Dynamics, ranked 125 Massachusetts employers by analyzing employee responses to a confidential 24-question survey. The survey covered several topics including benefits, management and employee engagement.

“We are very proud to be named as a Top Place to Work in Massachusetts, a key region for our business,” said Warren Stone, Head of Research & Applied Commercial, MilliporeSigma. “We thank the employees surveyed for showing their engagement and commitment to the acceleration of science. It shows a sincere sense of connection and pride to both the community and our customers.”

Top Places to Work recognizes the best places to work in the state based on internal employee surveys. Employers who enter to be surveyed are placed into one of four groups: small, with 50 to 99 employees; midsize, with 100 to 249 workers; large, with 250 to 999; and largest, with 1,000 or more. In total, the Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany employ approximately 2,300 people in Massachusetts. MilliporeSigma employees approximately 1,100 people in Massachusetts.

About the Life Science Business of Merck KGaA, Darmstadt, Germany
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has 19,000 employees and 65 manufacturing sites worldwide, with a portfolio of more than 300,000 products enabling scientific discovery. Udit Batra is the global chief executive officer of MilliporeSigma.

Merck KGaA, Darmstadt, Germany completed its $17 billion acquisition of Sigma-Aldrich in November 2015, creating a leader in the $125 billion global life science industry.

Merck KGaA of Darmstadt, Germany is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. The company has six businesses – Biopharmaceuticals, Consumer Health, Allergopharma, Biosimilars, Life Science and Performance Materials – and generated sales of €12.85 billion in 2015. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges.

Merck KGaA, Darmstadt, Germany is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. The company holds the global rights to the name and the trademark “Merck” internationally except for the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.